Skip to main content
. Author manuscript; available in PMC: 2011 Dec 4.
Published in final edited form as: Neuroimage. 2009 Dec 4;49(4):2915–2923. doi: 10.1016/j.neuroimage.2009.11.057

TABLE 2.

Characteristics of participants in the study.

Characteristic Group

Controls (n=19) Turner Syndrome (n=24)

Age yrs [mean(s.d), range] 27 (7.9), 17-45 26 (7.3), 16-40
VIQ [mean(s.d)] 100 (13.0) 106 (14.4)
PIQ [mean(s.d)] a 107 (13.9) 96 (19.2)
TBV cm3 [mean(s.d)] 1176.6 (60.8) 1204.3 (87.5)
Handedness [R/L] 18/1 23/1
X chromosome [parental/maternal] - 17/7
Ever taken estrogen replacement 1 24
Ever taken androgen replacement - 11
Ever taken growth hormone - 12

Abbreviations: VIQ(verbal intelligence quotient), PIQ(performance intelligence quotient), TBV(total brain volume)

a

Significant group difference (p=0.018)